230 related articles for article (PubMed ID: 11733266)
1. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion.
Weiss JN; Bynoe LA
Ophthalmology; 2001 Dec; 108(12):2249-57. PubMed ID: 11733266
[TBL] [Abstract][Full Text] [Related]
2. Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study.
Feltgen N; Junker B; Agostini H; Hansen LL
Ophthalmology; 2007 Apr; 114(4):716-23. PubMed ID: 17141322
[TBL] [Abstract][Full Text] [Related]
3. Retinal endovascular surgery for central retinal vein occlusion: initial experience of four surgeons.
Bynoe LA; Hutchins RK; Lazarus HS; Friedberg MA
Retina; 2005; 25(5):625-32. PubMed ID: 16077361
[TBL] [Abstract][Full Text] [Related]
4. Updated cannulation technique for tissue plasminogen activator injection into peripapillary retinal vein for central retinal vein occlusion.
van Overdam KA; Missotten T; Spielberg LH
Acta Ophthalmol; 2015 Dec; 93(8):739-44. PubMed ID: 26310993
[TBL] [Abstract][Full Text] [Related]
5. Short-term results of endovascular surgery with tissue plasminogen activator injection for central retinal vein occlusion.
Ishida M; Abe S; Nakagawa T; Hayashi A
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2135-2140. PubMed ID: 28803326
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion.
Elman MJ; Raden RZ; Carrigan A
Trans Am Ophthalmol Soc; 2001; 99():219-21; discussion 222-3. PubMed ID: 11797310
[TBL] [Abstract][Full Text] [Related]
7. Retinal surgery for treatment of central retinal vein occlusion.
Weiss JN
Ophthalmic Surg Lasers; 2000; 31(2):162-5. PubMed ID: 10743932
[TBL] [Abstract][Full Text] [Related]
8. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
Chang W; Garg SJ; Maturi R; Hsu J; Sivalingam A; Gupta SA; Regillo CD; Ho AC
Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021
[TBL] [Abstract][Full Text] [Related]
9. Retinal vein cannulation with prolonged infusion of tissue plasminogen activator (t-PA) for the treatment of experimental retinal vein occlusion in dogs.
Tameesh MK; Lakhanpal RR; Fujii GY; Javaheri M; Shelley TH; D'Anna S; Barnes AC; Margalit E; Farah M; De Juan E; Humayun MS
Am J Ophthalmol; 2004 Nov; 138(5):829-39. PubMed ID: 15531319
[TBL] [Abstract][Full Text] [Related]
10. Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion.
Hattenbach LO; Friedrich Arndt C; Lerche R; Scharrer I; Baatz H; Margaron F; Richard G; Behrens-Baumann W; Ohrloff C
Retina; 2009; 29(7):932-40. PubMed ID: 19584651
[TBL] [Abstract][Full Text] [Related]
11. Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein.
Weiss JN
Am J Ophthalmol; 1998 Jul; 126(1):142-4. PubMed ID: 9683166
[TBL] [Abstract][Full Text] [Related]
12. The Central Retinal Vein Bypass Study: a trial of laser-induced chorioretinal venous anastomosis for central retinal vein occlusion.
McAllister IL; Gillies ME; Smithies LA; Rochtchina E; Harper CA; Daniell MD; Constable IJ; Mitchell P
Ophthalmology; 2010 May; 117(5):954-65. PubMed ID: 20163872
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA
Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of vitrectomy and internal limiting membrane peeling for macular edema secondary to central retinal vein occlusion and hemiretinal vein occlusion.
Park DH; Kim IT
Retina; 2010 Jan; 30(1):117-24. PubMed ID: 19996831
[TBL] [Abstract][Full Text] [Related]
15. Comparison of surgical treatments for central retinal vein occlusion; RON vs. cannulation of tissue plasminogen activator into the retinal vein.
Yamamoto T; Kamei M; Sakaguchi H; Oshima Y; Ikuno Y; Gomi F; Ohji M; Tano Y
Retina; 2009 Sep; 29(8):1167-74. PubMed ID: 19734765
[TBL] [Abstract][Full Text] [Related]
16. Thrombolytic therapy for central retinal vein occlusion: results of a pilot study.
Elman MJ
Trans Am Ophthalmol Soc; 1996; 94():471-504. PubMed ID: 8981710
[TBL] [Abstract][Full Text] [Related]
17. Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study.
Glacet-Bernard A; Kuhn D; Vine AK; Oubraham H; Coscas G; Soubrane G
Br J Ophthalmol; 2000 Jun; 84(6):609-13. PubMed ID: 10837386
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion.
Lahey JM; Fong DS; Kearney J
Ophthalmic Surg Lasers; 1999 Jun; 30(6):427-34. PubMed ID: 10392729
[TBL] [Abstract][Full Text] [Related]
19. Phase I trial on robot assisted retinal vein cannulation with ocriplasmin infusion for central retinal vein occlusion.
Willekens K; Gijbels A; Smits J; Schoevaerdts L; Blanckaert J; Feyen JHM; Reynaerts D; Stalmans P
Acta Ophthalmol; 2021 Feb; 99(1):90-96. PubMed ID: 32701225
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of vitreoretinal surgery for complications of branch retinal vein occlusion.
Amirikia A; Scott IU; Murray TG; Flynn HW; Smiddy WE; Feuer WJ
Ophthalmology; 2001 Feb; 108(2):372-6. PubMed ID: 11158815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
